@article{ref1,
title="Clozapine reduces recurrent suicidal and self-injurious behavior in treatment-refractory incarcerated individuals",
journal="Journal of correctional health care",
year="2022",
author="Zarzar, Theodore R. and Rosen, David L. and Mayo, James P. and O'Connell, Maria G. and Catlett, Terri L. and Reed, John G. and Williams, Joseph B. and Sheitman, Brian B.",
volume="ePub",
number="ePub",
pages="ePub-ePub",
abstract="This retrospective review examines clozapine's effects on treatment-refractory incarcerated individuals (N = 23) with recurrent thoughts of self-harm and/or self-injurious behavior. Emergent suicide risk assessments and days on suicide watch were assessed for the 3 months pre- and post-clozapine treatment. Total suicide assessments fell from 73 pre- to 14 post-clozapine, with a median of 2 assessments (interquartile range [IQR]: 1,5) pre-clozapine compared with 0 (IQR: 0,1) post-clozapine (p < 0.0001). Total days on suicide watch decreased from 104 days pre- to 32 post-clozapine, with a median of 3 days (IQR: 0,9) pre-clozapine compared with 0 (IQR: 0,0) post-clozapine (p = 0.0012). Emergency room visits and medical hospitalizations decreased substantially for all months of treatment. Clozapine treatment was associated with marked reductions in self-injurious thoughts and behaviors in high-risk incarcerated individuals.<p /> <p>Language: en</p>",
language="en",
issn="1078-3458",
doi="10.1089/jchc.21.02.0014",
url="http://dx.doi.org/10.1089/jchc.21.02.0014"
}